NCT02933710View on ClinicalTrials.gov

Postmarketing Surveillance Study for IMOJEV® in Republic of Korea

CompletedOBSERVATIONAL

Enrollment

50

Participants

Timeline

Start Date

July 21, 2016

Primary Completion Date

October 18, 2018

Study Completion Date

October 18, 2018

Conditions

Japanese Encephalitis

Trial Locations (1)

100-380

001, Seoul

All Listed Sponsors

lead

Sanofi Pasteur, a Sanofi Company

INDUSTRY

NCT02933710 - Postmarketing Surveillance Study for IMOJEV® in Republic of Korea | Biotech Hunter | Biotech Hunter